FDA NEWS

Recalls and Safety Alerts: New Instructions for Using Talecris IG Syringes
Talecris Biotherapeutics has revised the directions for administering some of the company's immune globulin products -- ones that come in uncalibrated prefilled 2 mL syringes with fixed needles. The products are HyperRAB? S/D , which is an anti-rabi...

Viril-ity Power (VIP) Tablets
Product recalled because it contains a potentially harmful, undeclared ingredient that may interact with nitrates found in some prescription drugs and can lower blood pressure to life-threatening levels.

Mommy's Bliss Nipple Cream
Product contains potentially harmful ingredients that may cause respiratory distress or vomiting and diarrhea in infants.

Trasylol (aprotinin injection)
Bayer Pharmaceuticals notified the FDA of their intent to remove all remaining supplies of Trasylol from hospital pharmacies and warehouses.

Cardinal Alcohol-Free Mouthwash
Additional lot recalled because of the presence of Burkholderia cepacia.

Heparin Sodium Injection
FDA requests that health professionals and facilities review and examine all drug/device storage areas to ensure that all recalled heparin products have been removed and are no longer available for patient use.

Solodyn (minocycline HCL) Extended Release Tablets 90 mg
Recall of certain lots because one bottle of Solodyn contained Azasan (azathioprine).

Recalls and Safety Alerts: Unsafe Use of Extended-Release Tussionex Suspension
FDA is cautioning healthcare professionals, patients and caregivers about the unsafe use of Tussionex Pennkinetic Extended-Release Suspension. This product is a long-acting cough suppressant containing hydrocodone, a narcotic antitussive, and chlorp...

Recalls and Safety Alerts: Updated Labeling Changes for Tamiflu and Relenza
Roche Laboratories has updated information on neuropsychiatric events for Tamiflu (oseltamivir phosphate), a drug that's used to treat or prevent influenza in patients 1 year and older. The revised labeling reminds practitioners that some patients...

Drug to be Discontinued: Geocillin (carbenicillin indanyl sodium) tablets 382 mg
Pfizer has discontinued this product. There are no other FDA approved manufacturers currently for carbenicillin tablets.